Form 4 for CRMD CorMedix Inc.
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001213900-25-089216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-18 | 2025-09-16 | CRMD | Duncan Gregory Scott | Dir | M - OptEx | $8.32 | +13.3K | 38.3K | +53% | +$110.9K |
| D | 2025-09-18 | 2025-09-16 | CRMD | Duncan Gregory Scott | Dir | M - OptEx | $0.00 | -13.3K | 6,667 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | M | A | 13,333 | $8.32 | 38,333 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-09-16 | M | D | 13,333 | $0.00 | 6,667 | D | $8.32 · — to 2031-01-10 | 13,333 Common Stock | (F1) These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. |